BOA Biomedical
Boston
About BOA Biomedical
BOA Biomedical (BOA) has a platform technology for rapid diagnosis and treatment of infectious diseases. Developed at the Wyss Institute for Biologically Inspired Engineering, BOA licensed the initial technology for this medical device from Harvard University in 2018.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Last round: Series Unknown (Mar 2021)
- Website: boabiomedical.com
Social Profiles
Canonical: https://fsome.com/organization/boa-biomedical-3278696 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.